The efficacy of administrating a sweet-tasting solution for reducing the pain related to dental injections in children: A randomized controlled trial.

BACKGROUND: Anaesthetic injections are an unpleasant experience for children in the dental office. Oral intake of sweet substances by newborns has been shown to be effective in reducing pain. AIM: The purpose of this study was to determine whether a prior administration of a sweet-tasting solution has an effect on dental injection pain. DESIGN: A total of 56 healthy children needing bilateral maxillary primary canine extraction were included in this split-mouth randomized clinical trial. In the test side, dental injection (local infiltration) was applied after the patient received a sweet-tasting solution, while in the control side sterile water was administered. The patients' demographic characteristics, body mass index (BMI), and sweet taste preference were recorded. Pain perception during injection was measured using visual analogue scale (VAS) and sound, eye, body movement (SEM). RESULTS: Mean VAS (28.30 ± 6.43) and SEM (2.14 ± 0.78) in the test side were lower than the control side (45.80 ± 7.17 and 2.95 ± 1.00). It was shown that higher BMI was associated with reduction in the analgesic effect, while the individual's tendency to sweetness increased pain reduction. CONCLUSIONS: Sweet taste administration before dental injections in children helps to control the associated pain. This effect is influenced by the individual's sweet taste tendency and BMI.

Pain Perception Due to Dental Injection by Smartject: Split Mouth Design Study.

STATEMENT OF THE PROBLEM: Dental injection is one of the most fearful procedures in dental setting, especially for children. Many researchers have attempted to find a painless method. As computer controlled local anesthesia delivery system devices (CCLADs) allow the speed rate and pressure of injection solution to be controlled, they may cause less pain during injection in comparison to the conventional method. PURPOSE: The aim of this study was to compare pain perception in dental injection by Smartject with conventional technique. MATERIALS AND METHOD: The present study was a randomized single-blind crossover clinical trial. The participants consisted of 50 healthy volunteer dental students. They received a topical anesthetic agent plus injection in maxillary premolar buccal mucosa via conventional technique on one side (control) and a topical anesthetics agent plus injection in maxillary premolar buccal mucosa by Smartject on the other side (experimental). The first injection method was chosen based on block randomization table. A blind person recorded the subjects' pain perception of injection based on the visual analogue scale (VAS) in the two groups. Repeated measure test, independent Student t-test and Student paired t- test were used. Statistical significance was defined at p< 0.05. RESULTS: There was statistically significant difference in VAS score between Smartject and the conventional technique. The mean of VAS scores for Smartject and the conventional technique were 14.5±7.4 and 24±12.1, respectively. CONCLUSION: It is suggested, needle penetration is not the main reason of pain during injection. Inconsistent fluid pressure created by injected anesthetic solution on nerve fibers is more impressive in pain development. Hence, Smartject as a CCLAD can be considered as an appropriate device for dental injection.

Antibiotic therapy for prevention of fistula in-ano after incision and drainage of simple perianal abscess: A randomized single blind clinical trial.

BACKGROUND: Much controversy exists regarding the role of antibiotics in the development of fistula in-ano after incision and drainage. We evaluated the role of postoperative antibiotics in the prevention of fistula in-ano after incision and drainage of perianal abscess. METHODS: In a randomized single blind clinical trial study, 307 patients were randomly selected from those referring for incision and drainage of perianal abscess at Shahid Faghihi Hospital, Shiraz, Iran, during September 2013 to September 2014. Patients were allocated randomly either to receive 7 days of oral metronidazole and ciprofloxacin in addition to their standard care or to only receive standard care without any antibiotics after they were discharged from the hospital. Patients were followed for 3 months and final results were evaluated. The study was registered at the clinical trial registry (www.irct.ir; Irct201311049936n7). RESULTS: Seven patients were lost to follow-up. Those who used prophylactic antibiotics (n = 155) had significantly lower rates of fistula formation compared with those who did not use any medication (n = 144; P < .001). Men had higher rates of fistula formation (P = .002). Patients who used more cigarettes had higher rates of fistula development (P = .001). In the univariate analysis, only postoperative antibiotic use showed a protective role against fistula formation (odds ratio = 0.426; confidence interval, 0.206-0.881). In the regression analysis postoperative antibiotic use remained protective against fistula development (odds ratio = 0.371; confidence interval, 0.196-0.703), furthermore male sex presented as a risk factor for developing fistula in-ano (odds ratio = 3.11; confidence interval, 1.31-7.38). CONCLUSION: Postoperative prophylactic antibiotic therapy including ciprofloxacin and metronidazole play an important role in preventing fistula in-ano formation. Considering the complications of fistula in-ano formation and the minor side effects of antibiotic therapy, based on our results, a 7-10 course of postoperative antibiotics is advised after incision and drainage of perianal abscess.